244 related articles for article (PubMed ID: 30111377)
1. Detection of GNAS mutations in intramuscular / cellular myxomas as diagnostic tool in the classification of myxoid soft tissue tumors.
Sunitsch S; Gilg MM; Kashofer K; Gollowitsch F; Leithner A; Liegl-Atzwanger B
Diagn Pathol; 2018 Aug; 13(1):52. PubMed ID: 30111377
[TBL] [Abstract][Full Text] [Related]
2. Identification of novel GNAS mutations in intramuscular myxoma using next-generation sequencing with single-molecule tagged molecular inversion probes.
Bekers EM; Eijkelenboom A; Rombout P; van Zwam P; Mol S; Ruijter E; Scheijen B; Flucke U
Diagn Pathol; 2019 Feb; 14(1):15. PubMed ID: 30736805
[TBL] [Abstract][Full Text] [Related]
3. Karyotyping and analysis of GNAS locus in intramuscular myxomas.
Panagopoulos I; Gorunova L; Lobmaier I; Bjerkehagen B; Heim S
Oncotarget; 2017 Mar; 8(13):22086-22094. PubMed ID: 28160572
[TBL] [Abstract][Full Text] [Related]
4. Next generation sequencing for GNAS uncovers CD34 as a sensitive marker for intramuscular myxoma.
Libbrecht L; Bempt IV; Schubert T; Sciot R; Galant C
Ann Diagn Pathol; 2019 Dec; 43():151409. PubMed ID: 31726379
[TBL] [Abstract][Full Text] [Related]
5. Cellular/intramuscular myxoma and grade I myxofibrosarcoma are characterized by distinct genetic alterations and specific composition of their extracellular matrix.
Willems SM; Mohseny AB; Balog C; Sewrajsing R; Briaire-de Bruijn IH; Knijnenburg J; Cleton-Jansen AM; Sciot R; Fletcher CD; Deelder AM; Szuhai K; Hensbergen PJ; Hogendoorn PC
J Cell Mol Med; 2009 Jul; 13(7):1291-301. PubMed ID: 19320777
[TBL] [Abstract][Full Text] [Related]
6. [Intramuscular myxoma of the lower leg].
Luebke AM; Gocke C; Priemel M; Grob TJ; Zustin J
Pathologe; 2013 Jul; 34(4):360-3. PubMed ID: 23179208
[TBL] [Abstract][Full Text] [Related]
7. GNAS1 mutations occur more commonly than previously thought in intramuscular myxoma.
Delaney D; Diss TC; Presneau N; Hing S; Berisha F; Idowu BD; O'Donnell P; Skinner JA; Tirabosco R; Flanagan AM
Mod Pathol; 2009 May; 22(5):718-24. PubMed ID: 19287459
[TBL] [Abstract][Full Text] [Related]
8. Juxta-articular myxoma and intramuscular myxoma are two distinct entities. Activating Gs alpha mutation at Arg 201 codon does not occur in juxta-articular myxoma.
Okamoto S; Hisaoka M; Meis-Kindblom JM; Kindblom LG; Hashimoto H
Virchows Arch; 2002 Jan; 440(1):12-5. PubMed ID: 11942570
[TBL] [Abstract][Full Text] [Related]
9. Prevalence and Clinical Features of Mazabraud Syndrome: A Multicenter European Study.
Majoor BCJ; van de Sande MAJ; Appelman-Dijkstra NM; Leithner A; Jutte PC; Vélez R; Perlaky T; Staals EL; Bovée JVMG; Hamdy NAT; Dijkstra SPD
J Bone Joint Surg Am; 2019 Jan; 101(2):160-168. PubMed ID: 30653046
[TBL] [Abstract][Full Text] [Related]
10. Activating GNAS mutations in parosteal osteosarcoma.
Carter JM; Inwards CY; Jin L; Evers B; Wenger DE; Oliveira AM; Fritchie KJ
Am J Surg Pathol; 2014 Mar; 38(3):402-9. PubMed ID: 24525511
[TBL] [Abstract][Full Text] [Related]
11. A mutation spectrum that includes GNAS, KRAS and TP53 may be shared by mucinous neoplasms of the appendix.
Hara K; Saito T; Hayashi T; Yimit A; Takahashi M; Mitani K; Takahashi M; Yao T
Pathol Res Pract; 2015 Sep; 211(9):657-64. PubMed ID: 26160192
[TBL] [Abstract][Full Text] [Related]
12. Molecular and clinicopathological features of appendiceal mucinous neoplasms.
Yanai Y; Saito T; Hayashi T; Akazawa Y; Yatagai N; Tsuyama S; Tomita S; Hirai S; Ogura K; Matsumoto T; Wada R; Yao T
Virchows Arch; 2021 Mar; 478(3):413-426. PubMed ID: 32821969
[TBL] [Abstract][Full Text] [Related]
13. Analysis of GNAS1 mutations in myxoid soft tissue and bone tumors.
Walther I; Walther BM; Chen Y; Petersen I
Pathol Res Pract; 2014 Jan; 210(1):1-4. PubMed ID: 24268734
[TBL] [Abstract][Full Text] [Related]
14. Activating Gs(alpha) mutation in intramuscular myxomas with and without fibrous dysplasia of bone.
Okamoto S; Hisaoka M; Ushijima M; Nakahara S; Toyoshima S; Hashimoto H
Virchows Arch; 2000 Aug; 437(2):133-7. PubMed ID: 10993273
[TBL] [Abstract][Full Text] [Related]
15. Intramuscular myxoma of the cervical muscles with GNAS mutation.
Pilloni G; Ajello M; Melcarne A; Marengo N; Zenga F; Garbossa D; Ducati A; Tartara F
J Neurosurg Sci; 2019 Aug; 63(4):485-487. PubMed ID: 29115102
[No Abstract] [Full Text] [Related]
16. Novel Association of Odontogenic Myxoma with Constitutional Chromosomal 1q21 Microduplication: Case Report and Review of the Literature.
Best-Rocha A; Patel K; Hicks J; Edmonds JL; Paldino MJ; Wu H
Pediatr Dev Pathol; 2016; 19(2):139-45. PubMed ID: 26230961
[TBL] [Abstract][Full Text] [Related]
17. GNAS mutation detection in circulating cell-free DNA is a specific predictor for intraductal papillary mucinous neoplasms of the pancreas, especially for intestinal subtype.
Hata T; Mizuma M; Motoi F; Omori Y; Ishida M; Nakagawa K; Hayashi H; Morikawa T; Kamei T; Furukawa T; Unno M
Sci Rep; 2020 Oct; 10(1):17761. PubMed ID: 33082481
[TBL] [Abstract][Full Text] [Related]
18. Genetic characterization of intramuscular myxomas.
Hatchett WJ; Brunetti M; Andersen K; Tandsæther MR; Lobmaier I; Lund-Iversen M; Lien-Dahl T; Micci F; Panagopoulos I
Pathol Oncol Res; 2024; 30():1611553. PubMed ID: 38317844
[No Abstract] [Full Text] [Related]
19. Mutational analysis of high-grade spindle cell sarcoma of the femur in Mazabraud's syndrome.
Calleja M; Amary F; O'Donnell P
Skeletal Radiol; 2019 Jan; 48(1):151-157. PubMed ID: 29804209
[TBL] [Abstract][Full Text] [Related]
20. Lobular endocervical glandular hyperplasia is a neoplastic entity with frequent activating GNAS mutations.
Matsubara A; Sekine S; Ogawa R; Yoshida M; Kasamatsu T; Tsuda H; Kanai Y
Am J Surg Pathol; 2014 Mar; 38(3):370-6. PubMed ID: 24145653
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
